WO1997027148A1 - Bioactive glass compositions and methods of treatment using bioactive glass - Google Patents

Bioactive glass compositions and methods of treatment using bioactive glass Download PDF

Info

Publication number
WO1997027148A1
WO1997027148A1 PCT/US1997/001785 US9701785W WO9727148A1 WO 1997027148 A1 WO1997027148 A1 WO 1997027148A1 US 9701785 W US9701785 W US 9701785W WO 9727148 A1 WO9727148 A1 WO 9727148A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
tooth structure
contacting
tooth
bioactive
Prior art date
Application number
PCT/US1997/001785
Other languages
French (fr)
Other versions
WO1997027148A9 (en
Inventor
Leonard J. Litkowski
Gary D. Hack
David C. Greenspan
Original Assignee
Usbiomaterials Corporation
University Of Maryland At Baltimore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NZ331514A priority Critical patent/NZ331514A/en
Priority to DE69731184T priority patent/DE69731184T2/en
Application filed by Usbiomaterials Corporation, University Of Maryland At Baltimore filed Critical Usbiomaterials Corporation
Priority to BR9707219-2A priority patent/BR9707219A/en
Priority to EP97906489A priority patent/EP0877716B1/en
Priority to SK1029-98A priority patent/SK102998A3/en
Priority to IL12556097A priority patent/IL125560A0/en
Priority to AU21171/97A priority patent/AU723659B2/en
Priority to AT97906489T priority patent/ATE279380T1/en
Priority to SI9720016A priority patent/SI9720016A/en
Priority to JP52713197A priority patent/JP4180657B2/en
Priority to CA002244722A priority patent/CA2244722C/en
Publication of WO1997027148A1 publication Critical patent/WO1997027148A1/en
Publication of WO1997027148A9 publication Critical patent/WO1997027148A9/en
Priority to NO983490A priority patent/NO983490L/en
Priority to BG102722A priority patent/BG102722A/en
Priority to HK99104392A priority patent/HK1019222A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C4/00—Compositions for glass with special properties
    • C03C4/0007—Compositions for glass with special properties for biologically-compatible glass
    • C03C4/0021—Compositions for glass with special properties for biologically-compatible glass for dental use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/15—Compositions characterised by their physical properties
    • A61K6/17—Particle size
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/802—Preparations for artificial teeth, for filling teeth or for capping teeth comprising ceramics
    • A61K6/807—Preparations for artificial teeth, for filling teeth or for capping teeth comprising ceramics comprising magnesium oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/831—Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
    • A61K6/836—Glass
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22—Peroxides; Oxygen; Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C12/00—Powdered glass; Bead compositions
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C3/00—Glass compositions
    • C03C3/04—Glass compositions containing silica
    • C03C3/076—Glass compositions containing silica with 40% to 90% silica, by weight
    • C03C3/097—Glass compositions containing silica with 40% to 90% silica, by weight containing phosphorus, niobium or tantalum
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03C—CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C4/00—Compositions for glass with special properties
    • C03C4/0007—Compositions for glass with special properties for biologically-compatible glass
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Definitions

  • BIOACTIVE GLASS COMPOSITIONS AND METHODS OF TREATMENT USING BIOACTIVE GLASS
  • the present invention relates to bioactive glass compositions. More particularly, the present invention relates to improved compositions of bioactive glass including particles having combinations of size ranges significantly lower than previous compositions. The present invention also relates to various methods of treatment including the use of such bioactive glass compositions.
  • U.S. Patent No. 5,427,768 discloses calcium phosphate solutions which are supersaturated with respect to calcium phosphate solids and carbon dioxide. The solutions deposit calcium phosphate compounds with or without fluoride on and in the tooth weaknesses such as dental caries, exposed root, or dentin.
  • U.S. Patent Nos. 5,268,167 and 5,037,639 disclose the use of amo ⁇ hous calcium compounds such as amo ⁇ hous calcium phosphate, amo ⁇ hous calcium phosphate fluoride and amo ⁇ hous calcium carbonate phosphate for use in remineralizing teeth. These amo ⁇ hous compounds, when applied to _ dental tissue prevent and/or repair dental weaknesses.
  • Demineralization eventually leads to cavitation of enamel coating such that there is exposure ofthe underlying tooth structure.
  • this type of decay is treated by drilling out the decayed region and inserting a semi-permanent filling material.
  • a semi-permanent filling material there is a need for a less invasive means of arresting and reversing decay.
  • Prophylactic pit and fissure sealants have become widely used in preventing decay in areas that are particularly at risk for decay. These sealants have included polymer or other cements that require a dry application and the use of a fixing agent These sealants are temporary and do not provide for an optimal seal.
  • Liners and bases are materials that are used to treat newly exposed tooth surfaces such as those surfaces exposed by drilling. After a cavity is prepared, it is common practice to apply a liner or base before filling the cavity with a filling material.
  • a liner is a thin coating of material and a base is a thicker coating.
  • Liner and base materials are designed to decrease permeability of dentin at the tooth material interface and protect against microleakage around and through the fill material and to seal dentin tubules.
  • Earlier liners or "cavity varnishes” include materials such as organic "gums" dissolved in organic solvents. Upon evaporation of the organic solvent, the gum is left behind.
  • 5,296,026 discloses glass phosphate cement compositions and methods for their use as surgical implant materials to fill cavities in bone and canals in teeth.
  • the cement compositions include P 2 O 5 , CaO, SrO and Na O in combination with an aqueous liquid with or without therapeutic agents. Mixing the powder and liquid results in a hardening reactions.
  • the cement When the cement is implanted into hard tissue, it serves as a filler/graft material and along with the release of leachable constituents it can assist in the healing and maintenance of healthy bone.
  • the glass has been reported to be bacteriostatic or bacteriocidal most likely related to the change in pH induced by the dissolution ofthe ions from the surface ofthe glass and lack of bacterial adherence to the glass surface.
  • the bonding ofthe glass to bone begins with the exposure ofthe glass to aqueous solutions. Na + in the glass exchanges with H+ from the body fluids causing the pH to increase. Ca and P migrate from the glass forming a Ca-P rich surface layer. Underlying this
  • Ca-P rich is a layer which becomes increasingly silica rich due to the loss of Na, Ca and P ions (U.S. Patent No. 4,851,046).
  • the 90-710 ⁇ m size range was determined to be the most effective for periodontal applications when in direct contact with bone. However, size ranges smaller than 90 ⁇ m were ineffective due to their high rate of reactivity and rapid reso ⁇ tion at the bony site. Moreover, size ranges smaller than 90 ⁇ m were determined to be ineffective in soft tissue sites also due to the presumption that the smaller particles were removed by macrophages
  • None ofthe foregoing methods or compositions provide for the combined advantages of both easy application and adherence to tooth structure including penetration into very small tooth structure defects and the opportunity for continued chemical and physical interaction with tooth structure after application.
  • the present invention relates to, for example, a bioactive glass composition including particulate bioactive and biocompatible glass including by weight percentage:
  • the particulate bioactive and biocompatible glass including particles less than 90 ⁇ m and an effective remineralizing amount of particles less than about 10 ⁇ m.
  • the present invention also relates to various methods of dental treatment including remineralization, sealing fissures and/or pits, lining tooth structure, treating decay, capping pulp, treating sensitive post surgical tooth structure, sealing dentinal tubules, and surface for tissue regeneration.
  • Figure 1 is a dentin control surface that has been treated with 37% phosphoric acid for 30 seconds to remove any smear layer after sectioning and grinding to emulate clinical sensitivity.
  • the surface has not been treated with bioactive glass in accordance with the present invention (2000X magnification).
  • Figure 2 is a dentin control surface that has been treated with 37% Phosphoric acid for 30 seconds to remove any smear layer after sectioning and grinding to emulate clinical sensitivity. The surface has not been treated with bioactive glass in accordance with the present invention (3000X magnification).
  • Figure 3 is a dentin surface that has been treated with an acid etch and treated with a bioactive glass composition in accordance with the present invention in water and glycerin for 2 minutes (Particle size range submicron to 90 ⁇ m, 1000X magnification).
  • Figure 4 is a dentin surface that has been acid etched and subsequently treated with a bioactive glass composition in accordance with the present invention in water and glycerin for 2 minutes. The surfaces were subsequently agitated and water rinsed for 2 minutes (Particle size range submicron to 20 ⁇ m, 2000X magnification).
  • Figure 5 is a dentin surface that has been acid etched and subsequently treated with a bioactive glass composition in accordance with the present invention and placed in water for 3 days. There was no subsequent agitation, but the surface was water rinsed for 2 minutes
  • Figure 6 is a dentin surface that has been acid etched and subsequently treated with a bioactive glass composition in accordance with the present invention in water and toothpaste for 2 minutes with agitation and a subsequent 2 minute water rinse (Particle size range submicron to 3 ⁇ m, 3000X magnification).
  • Figure 7 is a dentin surface that has been acid etched and treated with a bioactive glass composition in accordance with the present invention in water and toothpaste for 2 minutes with agitation and water rinse for 2 minutes (Particle size range submicron to 3 ⁇ m, 3500X magnification).
  • Figures 8 and 9 each include a dentin surface which has been acid etched with phosphoric acid, treated with a bioactive glass in accordance with the present invention for 2 minutes and immersed in a phosphate buffered saline for 5 days (Particle size range submicron).
  • Figure 10 depicts a dentin surface that has been acid etched and subsequently treated with a single application of a bioactive glass composition in accordance with the present invention.
  • Figure 11 depicts a dentin surface that has been acid etched and treated with three separate applications of a bioactive glass composition in accordance with the present invention.
  • Figure 12 is a Fourier Transform Spectroscopy (FTIR) performed on samples treated with optimal sizes and shaped particulate bioactive glass.
  • FTIR Fourier Transform Spectroscopy
  • the present invention provides a bioactive glass composition which is useful in, for example, enamel remineralization, incipient caries remineralization, carious dentin remineralization, caries prevention, arresting decay, reversing decay, anti-caries, pit and fissure sealants, prophylactic pastes, fluoride treatments, dentinal sealants, etc. It can also be included in toothpastes, liners, bases, gels, and restorative material e.g. packing, indirect pulp capping agent, etc. Compositions in accordance with the present invention are also useful in the treatment of surfaces after periodontal surgery to decrease dentinal sensitivity and enhance tissue attachment. The compositions are active in treating various defects associated with a variety of dental and other conditions and actually chemically and physically bond to the tooth thereby remineralizing tooth structure.
  • remineralization is the formation of hydroxyapatite.
  • the formation of hydroxyapatite begins with exposure of a bioactive glass composition to aqueous solutions. It is believed that the sodium ions (Na+) in the bioactive glass exchanges with H+ ions in body fluids causing pH to increase. Calcium and phosphorus then migrate from the bioactive glass forming a calcium-phosphorous rich surface layer. An underlying silica rich zone slowly increases as the sodium ion in the bioactive glass continues to exchange with the hydrogen ion ofthe solution. After time, the calcium-phosphorous rich layer crystallizes into a hydroxyapatite material. Collagen can become structurally integrated with the apatite agglomerates.
  • an effective remineralizing amount is any amount capable of forming hydroxyapatite.
  • a tooth structure is used herein, it is intended to refer to any feature or features of a tooth including but not limited to enamel, dentin, pulp, tooth root structure, cementum, root dentin, coronal dentin, any dental manufacture, etc.
  • a bioactive glass in accordance with the present invention is a glass composition that will form a layer of hydroxycarbonate apatite in vitro when placed in a simulated body fluid.
  • the following composition by weight will provide a bioactive glass: SiO 2 40-60
  • Bioactive glasses with these properties provide a more efficacious material for interaction with the tooth structure.
  • a biocompatible glass in accordance with the present invention is one that does not trigger an overwhelmingly adverse immune response.
  • bioactive glasses of specified particle sizes are particularly useful in treating the above-mentioned conditions.
  • su ⁇ rising results are obtained by the present invention where small and very small particles are combined.
  • the larger of these particles adhere to tooth structure and act as ionic reservoirs while the smaller are capable of entering and lodging inside of various tooth structure surface irregularities.
  • the larger of these particles provide a reservoir of additional calcium and phosphorous so that the mineralization, or depositing ofthe calcium phosphate layer begun by the small particles can continue.
  • Additional calcium and phosphorous can be leached to all tooth structure as well as to particles which have become attached to the inside or at the openings of surface irregularities of tooth structure such as dentinal tubules. This in turn provides for continuation ofthe entire reaction and continued growth ofthe smaller of these particles which have lodged inside or over the openings of such surface irregularities and can result in effectively coating or filling the surface irregularity.
  • This excess concentration of ions of calcium and phosphorous is necessary for continued reaction ofthe smaller of these particles to take place because the smaller particles quickly exhaust their ions as a result of their relatively high surface area.
  • the larger of these particles will react and release their ions more slowly as a longer term effect.
  • the larger of these particles will mechanically abrade the tooth surface opening various surface irregularities allowing small particles to enter and react with the surface irregularity.
  • the composition of the present invention is capable of penetrating into the depths ofthe smallest of surface irregularities and receiving a continued supply of ions from larger nearby particles so that it is able to grow after exhausting its stored ion supply. This is also very useful in sealing pits and fissures and a much more effective and long lasting seal is obtained.
  • extremely small particles are used.
  • the occlusion of these tubules leads to a significant reduction in the amount of sensitivity after, for example, periodontal surgery.
  • a mixture of particles less than two microns and larger than 45 microns in diameter are " used. It has been found that this combination yields a particularly effective composition.
  • Compositions in accordance with the present invention generally do not require time to set. Previous compositions were easily washed away by mechanical abrasion caused by brushing, exposure to mild acids in food, salivary flow or other liquids which normally come in contact with the teeth.
  • compositions in accordance with the present invention have been able to generally withstand significant agitation, rinsing with water and long term soaking in simulated saliva for five days. Moreover, many ofthe small particles of the present invention do not require a set time because they begin to chemically react and adhere to tooth structure as soon as they come into contact with these surfaces and fluids naturally present in the mouth. Although compositions in accordance with the present invention are effective with a single application, it is likely that multiple applications will be more efficacious.
  • the relatively small bioactive particulate glass ofthe present invention does not generate a significant immune response. Moreover, it is generally not engulfed by macrophages and rendered inactive in this application.
  • composition ofthe present invention is capable of providing a bioactive layer that will form a new structural layer which is a lasting remineralization of tooth structure. This has been verified by the reformation of a hydroxycarbonate apatite layer on dentin surfaces after treatment with compositions in accordance with the present invention with Fourier Transform Infrared spectroscopy (FTIR).
  • FTIR Fourier Transform Infrared spectroscopy
  • the particles have a particle size of about 20 microns with about 30 percent of the particles less than 10 microns. In another embodiment in accordance with the present invention the particles have an average particle size of 10 microns with at least 25% smaller than 2 microns.
  • compositions ofthe present invention may be formulated into toothpaste.
  • the particles may replace the silica currently used in toothpastes.
  • fluoride in the glass composition will enhance and strengthen the tooth structure.
  • the bioactive glass composition ofthe present invention can also be applied in a saline or distilled water based medium.
  • compositions ofthe present invention may also be formulated into mouthwash, gel or they may be applied by a dentist as a paste.
  • the starting product was a mixture containing (% by weight)
  • the mixture was melted in a covered platinum crucible at 1350° C for 2 hours to achieve homogenization.
  • the mixture was later quenched in deionized water at 0°C. Fritted glass was placed in an appropriate milling apparatus including ball mill, impact mill. The glass is milled for 2 hours and separated into appropriate size ranges.
  • the particle size range less than 90 ⁇ m was obtained using this process and confirmed by scanning electron microscopy and laser light scattering technique (Coulter LS 100). These mixtures were placed on the dentin slabs previously described. The exposure times to the dentin varied between two minutes with scrubbing to 3 days with no agitation.
  • the occlusion ofthe tubules is depicted in Figures 3-7. Visible in Figures 3-7 are total and partial occlusion ofthe dentin tubules with multiple size of small (1- 5 ⁇ m) particles present. In addition, larger particles that are visible that will act as reservoirs for the chemical composition. Early formation of hydroxyapatite crystals is beginning on the dentin surface confirmed by FTIR.
  • Figures 8 and 9 indicate the results obtainable by using submicron particles made in accordance with Example 1.
  • the samples of figures 8 and 9 are dentin surfaces which have been acid etched with phosphoric acid, treated with a bioactive glass for 2 minutes and immersed in a phosphate buffered saline for 5 days. With the lack of large particles for reservoir activity, there was less complete regeneration as confirmed by FTIR.
  • Example 3 was conducted to illustrate the benefits associated with multiple applications of compositions in accordance with the present invention.
  • an acid etched dentin surface was treated with a single treatment of bioactive particulate glass for two minutes and is depicted in Figure 10.
  • a dentin surface which has been acid etched and treated three times for two minutes is depicted in Figure 1 1.
  • Figure 10 shows significant penetration and occlusion ofthe tubules with a bonding over the surface ofthe dentin. There are not many large particles visible in Figure 10. In Figure 1 1 , there is even more significant penetration and occlusion ofthe tubules and a greater number of particles present. This demonstrates the benefits associated with multiple application including the tubules as well as increased presence of larger reservoirs of Ca and P ions. This also demonstrates inte ⁇ article welding ofthe larger particles to the smaller particles already bound to the surface.
  • Example 4 further illustrates the benefits associated with the use of particles less than 2 microns in combination particles greater than 45 microns in size.
  • FTIR spectra for the following samples are included in figure 12 to illustrate remineralization:
  • 15% were in the range of 20 to 38 microns and 15% were in the range of 38-90 microns.
  • the control sample provides a representative view ofthe spectrum of hydroxycarbonate apatite (HCA).
  • HCA hydroxycarbonate apatite
  • the shape ofthe peaks between wave number 1150 to 500 are very characteristic of HCA.
  • the peaks are disrupted after treatment with the acid etchant, especially in the 1150 to 900 range. This indicates a loss of the mineral components ofthe tooth structure, Calcium and Phosphorous.
  • Sample 3 shows a partiaJ remineralization ofthe Ca and P on the tooth structure.
  • Sample 4 was treated with the optimal size and shape mixture of bioactive glass and shows an almost complete remineralization.
  • a photomicrograph of Sample 4 is included as Figure 11.
  • Comparative Example 5 shows the benefits associated with the use of particles less than 10 microns in combination with particles greater than 45 microns in size over the use of just particles less than 2 microns or 53-90 ⁇ .
  • a control sample of untreated dentin surface was used in addition to treated surfaces as described below:
  • composition ofthe starting product for the following examples was the same as
  • Example 1 except the level of SiO 2 was 45%, 55%, and 60%. Also, the method of preparation was different. The mixture was melted in a covered platinum crucible at 1350°C for 2 hours to achieve homogenization. The mixture was poured into a slab, allowed to cool to room temperature and crushed with a hammer. Crushed glass fractions were then separated by sieving through a standard screen. Fractions were then separated and retained.
  • the particle size range less than 90 ⁇ m was obtained using this process and confirmed by scanning electron microscopy and laser light scattering technique (Coulter LS 100). These mixtures were placed on the dentin slabs previously described.

Abstract

A novel silica-based bioactive glass composition that can be used in conjunction with a delivery agent such as a toothpaste, gel, etc., having a particle size range < 90 νm which will form a rapid and continuous reaction with body fluids due to the immediate and long-term ionic release of Ca and P from the core silica particles, to produce a stable crystalline hydroxy carbonate apatite layer deposited onto and into the dentin tubules for the immediate and long-term reduction of dentin hypersensitivity and tooth surface remineralization.

Description

BIOACTIVE GLASS COMPOSITIONS AND METHODS OF TREATMENT USING BIOACTIVE GLASS
This application is a continuation-in-part application of copending U.S. Application Serial No. 08/597,936 filed February 7, 1996, the disclosure of which is hereby incoφorated by reference. This application is further a continuation-in-part application of copending U.S. Provisional Application Serial No. 60/010,795 filed January 29, 1996, the disclosure of which is hereby incoφorated by reference.
FIELD OF THE INVENTION
The present invention relates to bioactive glass compositions. More particularly, the present invention relates to improved compositions of bioactive glass including particles having combinations of size ranges significantly lower than previous compositions. The present invention also relates to various methods of treatment including the use of such bioactive glass compositions.
BACKGROUND OF THE INVENTION
Human tooth enamel naturally undergoes a process of demineralization. Exposure of enamel to saliva and food slowly leaches minerals from teeth and eventually leads to increased susceptibility to decay. This process of demineralization results in incipient caries which are typically very small defects in the enamel surface that are thus far usually left untreated. Carious dentin demineralization also may occur in patients that have exposed regions of dentin resulting from decay below the cementum-enamel junction. Accordingly, there has been much work associated with slowing this natural process of demineralization including the application of fluoride and other topical treatments.
For example, U.S. Patent No. 5,427,768 discloses calcium phosphate solutions which are supersaturated with respect to calcium phosphate solids and carbon dioxide. The solutions deposit calcium phosphate compounds with or without fluoride on and in the tooth weaknesses such as dental caries, exposed root, or dentin. U.S. Patent Nos. 5,268,167 and 5,037,639 disclose the use of amoφhous calcium compounds such as amoφhous calcium phosphate, amoφhous calcium phosphate fluoride and amoφhous calcium carbonate phosphate for use in remineralizing teeth. These amoφhous compounds, when applied to _ dental tissue prevent and/or repair dental weaknesses. The disadvantages of these methods include (1) a low pH necessary for the application which can be an irritant, (2) rapid reaction results in a very short term effect, (3) since these methods use solutions, the actual reactions are difficult to control from patient to patient, and (4) since the reactions are rapid and of short duration, the procedure must be repeated to maintain the effect. Also, both methods require maintaining at least one solution with pressurized CO2 prior to mixing delivery which makes the method difficult to incoφorate into an over-the-counter procedure.
Demineralization eventually leads to cavitation of enamel coating such that there is exposure ofthe underlying tooth structure. Typically, this type of decay is treated by drilling out the decayed region and inserting a semi-permanent filling material. However, there is a need for a less invasive means of arresting and reversing decay.
Prophylactic pit and fissure sealants have become widely used in preventing decay in areas that are particularly at risk for decay. These sealants have included polymer or other cements that require a dry application and the use of a fixing agent These sealants are temporary and do not provide for an optimal seal.
Liners and bases are materials that are used to treat newly exposed tooth surfaces such as those surfaces exposed by drilling. After a cavity is prepared, it is common practice to apply a liner or base before filling the cavity with a filling material. A liner is a thin coating of material and a base is a thicker coating. Liner and base materials are designed to decrease permeability of dentin at the tooth material interface and protect against microleakage around and through the fill material and to seal dentin tubules. Earlier liners or "cavity varnishes" include materials such as organic "gums" dissolved in organic solvents. Upon evaporation of the organic solvent, the gum is left behind. Disadvantages associated with these organic gums are well documented and include leaky junctions, lack of adherence, acid vulnerability, etc. Another method of lining is disclosed in U.S. Patent No. 4,538,990 which describes applying a 1 to 30% w/v neutral oxalate salt solution, such as dipotassium oxalate to the smear layer and then applying a 0.5 to 3% w/v of an acidic oxalate salt solution such as monopotassium monohydrogen oxalate to the layer. Research has shown poor seal occlusion ofthe tubules with this method. U.S. Patent No. 5,296,026 discloses glass phosphate cement compositions and methods for their use as surgical implant materials to fill cavities in bone and canals in teeth. The cement compositions include P2O5, CaO, SrO and Na O in combination with an aqueous liquid with or without therapeutic agents. Mixing the powder and liquid results in a hardening reactions. When the cement is implanted into hard tissue, it serves as a filler/graft material and along with the release of leachable constituents it can assist in the healing and maintenance of healthy bone.
Various bioactive and biocompatible glasses have been developed as bone replacement materials. Studies have shown that these glasses will induce or aid osteogenesis in a physiologic systems. Hench et al, J Biomed. Mater. Res. 5:1 17-141 (1971). The bond developed between the bone and the glass has been demonstrated to be extremely strong and stable. Piotrowski et al., J. Biomed. Mater. Res. 9:47-61 (1975). Toxicology evaluation of the glasses has shown no toxic effects in bone or soft tissue in numerous in vitro andϊn vivo models. Wilson et al., J. Biomed. Mater. Res. 805-817 (1981). The glass has been reported to be bacteriostatic or bacteriocidal most likely related to the change in pH induced by the dissolution ofthe ions from the surface ofthe glass and lack of bacterial adherence to the glass surface. Stoor et al, Bioceramics Vol. 8 p. 253-258 Wilson et al (1995).
The bonding ofthe glass to bone begins with the exposure ofthe glass to aqueous solutions. Na+ in the glass exchanges with H+ from the body fluids causing the pH to increase. Ca and P migrate from the glass forming a Ca-P rich surface layer. Underlying this
Ca-P rich is a layer which becomes increasingly silica rich due to the loss of Na, Ca and P ions (U.S. Patent No. 4,851,046).
The behavior ofthe bioactive glass as solid implants in a dental application was reported by Stanley et al., Journal of Prostetic Dentistry, Vol. 58, pp. 607-613 (1987). Replicate tooth forms were fabricated and implanted into extracted incisor sockets of adult baboons. Successful attachment ofthe implants to surrounding bone was seen after histologic examination at six months. Clinical application of this technique is presently available for human use. Endosseous Ridge Maintenance Implant ERMI®. Particulate bioactive glass has been used for periodontal osseous defect repair (US Patent No. 4,851,046) utilizing a size range of 90-710 μm and a compositional range described in the following chart. Component Weight Percentage _
SiO2 40-55
CaO 10-30
Na2O 10-35 P205 2-8
CaF2 0-25
B203 0-10
Previously described data has shown that 60% silica is beyond the limit of bioactive melt derived glasses. Okasuki et al. Nippon Seramikbusu Kyokai Gakijutsu Konbuski, Vol. 99, pp. 1-6 (1991).
The 90-710 μm size range was determined to be the most effective for periodontal applications when in direct contact with bone. However, size ranges smaller than 90 μm were ineffective due to their high rate of reactivity and rapid resoφtion at the bony site. Moreover, size ranges smaller than 90 μm were determined to be ineffective in soft tissue sites also due to the presumption that the smaller particles were removed by macrophages
(see U.S. Patent No. 4,851,046). A size range of less than 200 μm was also found to be ineffective in certain bone defects (see U.S. Patent No. 5,204,106) due to the high rate of reactivity.
U.S. Patent No. 4,239,1 13 ("the '113 patent") also describes the use of a bone cement. The '1 13 patent only discloses bioactive glass ceramic powder having a particle size of 10-
200 microns. Moreover, the '1 13 patent also requires the use of methylmethacrylate (co)polymers and vitreous mineral fibers.
None ofthe foregoing methods or compositions provide for the combined advantages of both easy application and adherence to tooth structure including penetration into very small tooth structure defects and the opportunity for continued chemical and physical interaction with tooth structure after application.
Accordingly, it is an object ofthe present invention to provide a composition capable of chemical and physical interaction with tooth structure that is easily applied and readily adherent to tooth structure. It is a further object of the invention to provide a method of using such a bioactive glass composition to treat a variety of dental and other conditions. SUMMARY OF THE INVENTION
The present invention relates to, for example, a bioactive glass composition including particulate bioactive and biocompatible glass including by weight percentage:
SiO2 40-60
CaO 10-30
Na2O 10-35
P205 2-8
CaF2 0-25
B203 0-10
K2O 0-8
MgO 0-5, the particulate bioactive and biocompatible glass including particles less than 90 μm and an effective remineralizing amount of particles less than about 10 μm. The present invention also relates to various methods of dental treatment including remineralization, sealing fissures and/or pits, lining tooth structure, treating decay, capping pulp, treating sensitive post surgical tooth structure, sealing dentinal tubules, and surface for tissue regeneration.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is a dentin control surface that has been treated with 37% phosphoric acid for 30 seconds to remove any smear layer after sectioning and grinding to emulate clinical sensitivity. The surface has not been treated with bioactive glass in accordance with the present invention (2000X magnification).
Figure 2 is a dentin control surface that has been treated with 37% Phosphoric acid for 30 seconds to remove any smear layer after sectioning and grinding to emulate clinical sensitivity. The surface has not been treated with bioactive glass in accordance with the present invention (3000X magnification). Figure 3 is a dentin surface that has been treated with an acid etch and treated with a bioactive glass composition in accordance with the present invention in water and glycerin for 2 minutes (Particle size range submicron to 90 μm, 1000X magnification).
Figure 4 is a dentin surface that has been acid etched and subsequently treated with a bioactive glass composition in accordance with the present invention in water and glycerin for 2 minutes. The surfaces were subsequently agitated and water rinsed for 2 minutes (Particle size range submicron to 20 μm, 2000X magnification).
Figure 5 is a dentin surface that has been acid etched and subsequently treated with a bioactive glass composition in accordance with the present invention and placed in water for 3 days. There was no subsequent agitation, but the surface was water rinsed for 2 minutes
(Particle size range submicron to 90 μm, 2000X magnification).
Figure 6 is a dentin surface that has been acid etched and subsequently treated with a bioactive glass composition in accordance with the present invention in water and toothpaste for 2 minutes with agitation and a subsequent 2 minute water rinse (Particle size range submicron to 3 μm, 3000X magnification).
Figure 7 is a dentin surface that has been acid etched and treated with a bioactive glass composition in accordance with the present invention in water and toothpaste for 2 minutes with agitation and water rinse for 2 minutes (Particle size range submicron to 3 μm, 3500X magnification). Figures 8 and 9 each include a dentin surface which has been acid etched with phosphoric acid, treated with a bioactive glass in accordance with the present invention for 2 minutes and immersed in a phosphate buffered saline for 5 days (Particle size range submicron).
Figure 10 depicts a dentin surface that has been acid etched and subsequently treated with a single application of a bioactive glass composition in accordance with the present invention.
Figure 11 depicts a dentin surface that has been acid etched and treated with three separate applications of a bioactive glass composition in accordance with the present invention. Figure 12 is a Fourier Transform Spectroscopy (FTIR) performed on samples treated with optimal sizes and shaped particulate bioactive glass. DETAILED DESCRIPTION OF THE INVENTION
The present invention provides a bioactive glass composition which is useful in, for example, enamel remineralization, incipient caries remineralization, carious dentin remineralization, caries prevention, arresting decay, reversing decay, anti-caries, pit and fissure sealants, prophylactic pastes, fluoride treatments, dentinal sealants, etc. It can also be included in toothpastes, liners, bases, gels, and restorative material e.g. packing, indirect pulp capping agent, etc. Compositions in accordance with the present invention are also useful in the treatment of surfaces after periodontal surgery to decrease dentinal sensitivity and enhance tissue attachment. The compositions are active in treating various defects associated with a variety of dental and other conditions and actually chemically and physically bond to the tooth thereby remineralizing tooth structure.
As referred to herein, remineralization is the formation of hydroxyapatite. The formation of hydroxyapatite begins with exposure of a bioactive glass composition to aqueous solutions. It is believed that the sodium ions (Na+) in the bioactive glass exchanges with H+ ions in body fluids causing pH to increase. Calcium and phosphorus then migrate from the bioactive glass forming a calcium-phosphorous rich surface layer. An underlying silica rich zone slowly increases as the sodium ion in the bioactive glass continues to exchange with the hydrogen ion ofthe solution. After time, the calcium-phosphorous rich layer crystallizes into a hydroxyapatite material. Collagen can become structurally integrated with the apatite agglomerates. As hereinafter referred to, an effective remineralizing amount is any amount capable of forming hydroxyapatite.
As the term "a tooth structure" is used herein, it is intended to refer to any feature or features of a tooth including but not limited to enamel, dentin, pulp, tooth root structure, cementum, root dentin, coronal dentin, any dental manufacture, etc.
A bioactive glass in accordance with the present invention is a glass composition that will form a layer of hydroxycarbonate apatite in vitro when placed in a simulated body fluid. For example, the following composition by weight will provide a bioactive glass: SiO2 40-60
CaO 10-30
Na2O 10-35
P205 2-8
CaF2 0-25
B203 0-10
K2O 0-8
MgO 0-5
Bioactive glasses with these properties provide a more efficacious material for interaction with the tooth structure. A biocompatible glass in accordance with the present invention is one that does not trigger an overwhelmingly adverse immune response.
In accordance with the present invention, it has been found that bioactive glasses of specified particle sizes are particularly useful in treating the above-mentioned conditions. Specifically, suφrising results are obtained by the present invention where small and very small particles are combined. For example, when compositions including small particles that are capable of bonding with tooth structure (e.g. less than about 90 microns) as well smaller particles (e.g. less than about 10) are used in combination, the larger of these particles adhere to tooth structure and act as ionic reservoirs while the smaller are capable of entering and lodging inside of various tooth structure surface irregularities. The larger of these particles provide a reservoir of additional calcium and phosphorous so that the mineralization, or depositing ofthe calcium phosphate layer begun by the small particles can continue. Additional calcium and phosphorous can be leached to all tooth structure as well as to particles which have become attached to the inside or at the openings of surface irregularities of tooth structure such as dentinal tubules. This in turn provides for continuation ofthe entire reaction and continued growth ofthe smaller of these particles which have lodged inside or over the openings of such surface irregularities and can result in effectively coating or filling the surface irregularity. This excess concentration of ions of calcium and phosphorous is necessary for continued reaction ofthe smaller of these particles to take place because the smaller particles quickly exhaust their ions as a result of their relatively high surface area. The larger of these particles will react and release their ions more slowly as a longer term effect. Furthermore, the larger of these particles will mechanically abrade the tooth surface opening various surface irregularities allowing small particles to enter and react with the surface irregularity.
This effect is very beneficial in a variety of applications. For example, in preventing caries or decay, the composition of the present invention is capable of penetrating into the depths ofthe smallest of surface irregularities and receiving a continued supply of ions from larger nearby particles so that it is able to grow after exhausting its stored ion supply. This is also very useful in sealing pits and fissures and a much more effective and long lasting seal is obtained.
In some embodiments ofthe present invention, extremely small particles are used. For example, particles that are in the range of 2 μm to submicron fit inside dentin tubules that are approximately 1-2 μm in diameter. The occlusion of these tubules leads to a significant reduction in the amount of sensitivity after, for example, periodontal surgery. Preferably, a mixture of particles less than two microns and larger than 45 microns in diameter are"used. It has been found that this combination yields a particularly effective composition. Compositions in accordance with the present invention generally do not require time to set. Previous compositions were easily washed away by mechanical abrasion caused by brushing, exposure to mild acids in food, salivary flow or other liquids which normally come in contact with the teeth. However, some compositions in accordance with the present invention have been able to generally withstand significant agitation, rinsing with water and long term soaking in simulated saliva for five days. Moreover, many ofthe small particles of the present invention do not require a set time because they begin to chemically react and adhere to tooth structure as soon as they come into contact with these surfaces and fluids naturally present in the mouth. Although compositions in accordance with the present invention are effective with a single application, it is likely that multiple applications will be more efficacious.
Suφrisingly, the relatively small bioactive particulate glass ofthe present invention does not generate a significant immune response. Moreover, it is generally not engulfed by macrophages and rendered inactive in this application.
The composition ofthe present invention is capable of providing a bioactive layer that will form a new structural layer which is a lasting remineralization of tooth structure. This has been verified by the reformation of a hydroxycarbonate apatite layer on dentin surfaces after treatment with compositions in accordance with the present invention with Fourier Transform Infrared spectroscopy (FTIR).
In one embodiment in accordance with the present invention, the particles have a particle size of about 20 microns with about 30 percent of the particles less than 10 microns. In another embodiment in accordance with the present invention the particles have an average particle size of 10 microns with at least 25% smaller than 2 microns.
The compositions ofthe present invention may be formulated into toothpaste. In fact, the particles may replace the silica currently used in toothpastes. The addition of fluoride in the glass composition will enhance and strengthen the tooth structure. In addition to direct application ofthe bioactive glass to the teeth, the bioactive glass composition ofthe present invention can also be applied in a saline or distilled water based medium.
The compositions ofthe present invention may also be formulated into mouthwash, gel or they may be applied by a dentist as a paste.
Examples
The following working examples are non-limiting:
In vitro experiments were performed using a standardized slab of human tooth dentin from extracted teeth. These discs were cut from the extracted teeth using an Isomet diamond saw (Buchler Ltd.). The discs were 1.0 mm thick and the size ofthe tooth. The occlusal surfaces were ground on a series of wet silicon-carbide papers ranging from 320 to 600 grit.
This was done to standardize the test surfaces. The surfaces were treated with 37% phosphoric acid for 60 seconds to remove the smear layer created during the grinding process and open and enlarge all the dentin tubules (See Figures 1 and 2). The surface was rinsed with distilled water for 20 seconds and dried with a stream of oil free air. Each slab was split in half and the experimental material placed on one-half of the specimen as described in the examples. An untreated slab with open and enlarged tubules is shown in Figures 1 and 2.
Scanning electron microscopy was performed on the slab surface in each group. The slabs were mounted on scanning electron microscope stubs using sliver paste. All specimens were vacuum dried, sputter coated and examined in a JEOL-T200 scanning electron microscope. EXAMPLE I
The starting product was a mixture containing (% by weight)
SiO2 45 CaO 24.5
Na2O 24.5
P2O5 6
The mixture was melted in a covered platinum crucible at 1350° C for 2 hours to achieve homogenization. The mixture was later quenched in deionized water at 0°C. Fritted glass was placed in an appropriate milling apparatus including ball mill, impact mill. The glass is milled for 2 hours and separated into appropriate size ranges.
The particle size range less than 90 μm was obtained using this process and confirmed by scanning electron microscopy and laser light scattering technique (Coulter LS 100). These mixtures were placed on the dentin slabs previously described. The exposure times to the dentin varied between two minutes with scrubbing to 3 days with no agitation. The occlusion ofthe tubules is depicted in Figures 3-7. Visible in Figures 3-7 are total and partial occlusion ofthe dentin tubules with multiple size of small (1- 5 μm) particles present. In addition, larger particles that are visible that will act as reservoirs for the chemical composition. Early formation of hydroxyapatite crystals is beginning on the dentin surface confirmed by FTIR.
EXAMPLE 2
Figures 8 and 9 indicate the results obtainable by using submicron particles made in accordance with Example 1. The samples of figures 8 and 9 are dentin surfaces which have been acid etched with phosphoric acid, treated with a bioactive glass for 2 minutes and immersed in a phosphate buffered saline for 5 days. With the lack of large particles for reservoir activity, there was less complete regeneration as confirmed by FTIR. EXAMPLE 3
Example 3 was conducted to illustrate the benefits associated with multiple applications of compositions in accordance with the present invention. First, an acid etched dentin surface was treated with a single treatment of bioactive particulate glass for two minutes and is depicted in Figure 10. A dentin surface which has been acid etched and treated three times for two minutes is depicted in Figure 1 1.
Figure 10 shows significant penetration and occlusion ofthe tubules with a bonding over the surface ofthe dentin. There are not many large particles visible in Figure 10. In Figure 1 1 , there is even more significant penetration and occlusion ofthe tubules and a greater number of particles present. This demonstrates the benefits associated with multiple application including the tubules as well as increased presence of larger reservoirs of Ca and P ions. This also demonstrates inteφarticle welding ofthe larger particles to the smaller particles already bound to the surface.
EXAMPLE 4
Example 4 further illustrates the benefits associated with the use of particles less than 2 microns in combination particles greater than 45 microns in size. FTIR spectra for the following samples are included in figure 12 to illustrate remineralization:
Sample No. 1 Control (untreated dentin surface)
Sample No. 2 Acid etched dentin surface
Sample No. 3 Treated with particles of bioactive glass less than 2 microns in particle size for two minutes
Sample No. 4 Treated with particles of bioactive glass wherein 40% were less than 2 microns, 15% were in the range of 8 to 2 microns, 15% were in the range of 8 to 20 microns,
15% were in the range of 20 to 38 microns and 15% were in the range of 38-90 microns.
As illustrated in Figure 12, the control sample provides a representative view ofthe spectrum of hydroxycarbonate apatite (HCA). The shape ofthe peaks between wave number 1150 to 500 are very characteristic of HCA. In sample 2, the peaks are disrupted after treatment with the acid etchant, especially in the 1150 to 900 range. This indicates a loss of the mineral components ofthe tooth structure, Calcium and Phosphorous. Sample 3 shows a partiaJ remineralization ofthe Ca and P on the tooth structure. Sample 4 was treated with the optimal size and shape mixture of bioactive glass and shows an almost complete remineralization. A photomicrograph of Sample 4 is included as Figure 11.
EXAMPLE 5
Comparative Example 5 shows the benefits associated with the use of particles less than 10 microns in combination with particles greater than 45 microns in size over the use of just particles less than 2 microns or 53-90μ. A control sample of untreated dentin surface was used in addition to treated surfaces as described below:
Number of Sample Score Observations Applications Composition
Single 53-90μ 2 About 50% occluded tubules with large particles present
Control 0 No particles present
Single <2μ 2 Above 50% closure, no large particles seen
Control 0 Open tubules
Single 50% 53-90μ +3 75%+ tubules occluded 50% <2μ
Control 0 Open tubules
Multiple 53-90 2 Partial closure of tubules with large particles present
Control 0 Minimal occlusion seen Multiple <2μ 2 Partial closure of tubules with small particles present
Control 0 Minimal occlusion seen
Multiple 50% 53-90// +3 Best results— tubules closed; difficult to
50% <2μ find open tubules
Control 0 Minimal occlusion seen
All samples in the above Table were subjected to a moist environment for 24 hours and then dried for 48 hours.
As seen above, the combination of particles less than 2 microns and 53-90μ provided the best results. It is believed that the presence of both size ranges permits the smaller particles which have lodged in the tubules to continue growth after they have exhausted their own Ca and P ions and are able to make use of such ions from other nearby larger particles acting as reservoirs of Ca and P ions.
OTHER EXAMPLES
The composition ofthe starting product for the following examples was the same as
Example 1 except the level of SiO2 was 45%, 55%, and 60%. Also, the method of preparation was different. The mixture was melted in a covered platinum crucible at 1350°C for 2 hours to achieve homogenization. The mixture was poured into a slab, allowed to cool to room temperature and crushed with a hammer. Crushed glass fractions were then separated by sieving through a standard screen. Fractions were then separated and retained.
The particle size range less than 90 μm was obtained using this process and confirmed by scanning electron microscopy and laser light scattering technique (Coulter LS 100). These mixtures were placed on the dentin slabs previously described.
Samples containing 45%, 55%, and 60% SiO2 were utilized in the preparations with the same results seen in Example 1. Again, the key to this data was the presence ofthe size range of particles. Present in these examples are ranges up to 60% silica with a size range in particles from submicron to 90 micron showing like reactions to Example 1 on the dentin surfaces.
Although the present invention has been described in one or more embodiments, this description is not intended to in any way limit the scope ofthe claims.

Claims

We claim:
1. A bioactive glass composition comprising particulate bioactive and biocompatible glass including by weight percentage:
SiO2 40-60
CaO 10-30
Na2O 10-35
P.05 2-8
CaF2 0-25
B203 0-10
K2O 0-8
MgO 0-5, the particulate bioactive and biocompatible glass including particles less than 90 μm and an effective remineralizing amount of particles less than about 10 μm.
2. A method for preventing tooth decay comprising contacting a tooth structure with the composition of claim 1.
3. A method for treating tooth decay comprising contacting a tooth structure with the composition of claim 1.
4. A method for preventing incipient carries comprising contacting a tooth structure with the composition of claim 1.
5. A method for remineralizing enamel comprising contacting a tooth structure with the composition of claim 1.
6. A method for incipient caries remineralization comprising contacting a tooth structure with the composition of claim 1.
7. A method for sealing fissures in tooth structure comprising contacting a tooth structure with the composition of claim 1.
8. A method for sealing pits in tooth structure comprising contacting a tooth structure with the composition of claim 1.
9. A method for lining tooth structure comprising contacting a tooth structure with the composition of claim 1.
10. A method for capping pulp comprising contacting a tooth structure with the composition of claim 1.
11. A method for treating tooth hypersensitivity comprising contacting a tooth structure with the composition of claim 1.
12. A method for treating tooth structure after periodontal surgery comprising contacting a tooth structure with the composition of claim 1.
13. A composition for treating teeth comprising the composition of claim 1 and a toothpaste, liner, base, gel, restorative material, glycerin gel, mouthwash, prophylactic paste, or indirect pulp capping agent, or mixture thereof.
14. A bioactive glass composition comprising particulate bioactive and biocompatible glass including by weight percentage:
SiO2 40-60
CaO 10-30
Na2O 10-35
P205 2-8
CaF2 0-25
B203 0-10
K2O 0-8
MgO 0-5, the particulate bioactive and biocompatible glass including particles between 45 μ and 90 μm and an effective remineralizing amount of particles less than about 10 μm.
15. A method for preventing tooth decay comprising contacting a tooth structure with the composition of claim 14.
16. A method for treating tooth decay comprising contacting a tooth structure with the composition of claim 14.
17. A method for preventing incipient carries comprising contacting a tooth structure with the composition of claim 14.
18. A method for remineralizing enamel comprising contacting a tooth structure with the composition of claim 14.
19. A method for incipient caries remineralization comprising contacting a tooth structure with the composition of claim 14.
20. A method for sealing fissures in tooth structure comprising contacting a tooth structure with the composition of claim 14.
21. A method for sealing pits in tooth structure comprising contacting a tooth structure with the composition of claim 14.
22. A method for lining tooth structure comprising contacting a tooth structure with the composition of claim 14.
23. A method for capping pulp comprising contacting a tooth structure with the composition of claim 14.
24. A method for treating tooth hypersensitivity comprising contacting a tooth structure with the composition of claim 14.
25. A method for treating tooth structure after periodontal surgery comprising contacting a tooth structure with the composition of claim 14.
26. A composition for treating teeth comprising the composition of claim 14 and a toothpaste, liner, base, gel, restorative material, glycerin gel, mouthwash, prophylactic paste, or indirect pulp capping agent, or mixture thereof.
27. A bioactive glass composition comprising particulate bioactive and biocompatible glass including particles less than 90 μm and an effective remineralizing amount of particles less than about 10 μm.
28. A bioactive glass composition comprising particulate bioactive and biocompatible glass including particles less than 90 μm and an effective remineralizing amount of particles less than about 5 μm.
29. A bioactive glass composition comprising particulate bioactive and biocompatible glass including particles less than 90 μm and an effective remineralizing amount of particles less than about 2 μm.
30. A method for preventing tooth decay comprising contacting a tooth structure with the composition of claim 27.
31. A method for treating tooth decay comprising contacting a tooth structure with the composition of claim 27.
32. A method for preventing incipient carries comprising contacting a tooth structure with the composition of claim 27.
33. A method for remineralizing enamel comprising contacting a tooth structure with the composition of claim 27.
34. A method for incipient caries remineralization comprising contacting a tooth structure with the composition of claim 27.
35. A method for sealing fissures in tooth structure comprising contacting a tooth structure with the composition of claim 27.
36. A method for sealing pits in tooth structure comprising contacting a tooth structure with the composition of claim 27.
37. A method for lining tooth structure comprising contacting a tooth structure with the composition of claim 27.
38. A method for capping pulp comprising contacting a tooth structure with the composition of claim 27.
39. A method for treating tooth hypersensitivity comprising contacting a tooth structure with the composition of claim 27.
40. A method for treating tooth structure after periodontal surgery comprising contacting a tooth structure with the composition of claim 27.
41. A composition for treating teeth comprising the composition of claim 27 and a toothpaste, liner, base, gel, restorative material, glycerin gel, mouthwash, prophylactic paste, or indirect pulp capping agent, or mixture thereof.
42. A bioactive glass composition comprising particulate bioactive and biocompatible glass including particles less than 90 μm and particles less than about 2 μm.
43. A method for remineralizing tooth structure comprising contacting a tooth structure in need of remineralization with a bioactive glass composition including an effective remineralizing amount of particles less than 90 μm.
44. A bioactive glass composition comprising particulate bioactive and biocompatible glass including by weight percentage:
SiO2 40-60
CaO 10-30
Na2O 10-35
P205 2-8
CaF2 0-25
B203 0-10
K2O 0-8
MgO 0-5, the particulate bioactive and biocompatible glass including particles between 53 μ and 90 μm and an effective remineralizing amount of particles less than about 2 μm.
PCT/US1997/001785 1996-01-29 1997-01-29 Bioactive glass compositions and methods of treatment using bioactive glass WO1997027148A1 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SI9720016A SI9720016A (en) 1996-01-29 1997-01-29 Bioactive glass compositions and methods of treatment using bioactive glass
AT97906489T ATE279380T1 (en) 1996-01-29 1997-01-29 BIOACTIVE GLASS COMPOSITIONS FOR USE IN TREATING DENTAL STRUCTURES
BR9707219-2A BR9707219A (en) 1996-01-29 1997-01-29 Float glass compositions and treatment methods using bioactive glass.
DE69731184T DE69731184T2 (en) 1996-01-29 1997-01-29 BIOACTIVE GLASS COMPOSITIONS FOR USE FOR THE TREATMENT OF DENTAL STRUCTURES
SK1029-98A SK102998A3 (en) 1996-01-29 1997-01-29 Bioactive glass compositions and methods of treatment using bioactive glass
IL12556097A IL125560A0 (en) 1996-01-29 1997-01-29 A bioactive glass composition and a composition for treating teeth comprising the glass composition
JP52713197A JP4180657B2 (en) 1996-01-29 1997-01-29 Bioactive glass composition
NZ331514A NZ331514A (en) 1996-01-29 1997-01-29 A silica based bioactive glass composition having a particle size range less than 90 microns that can be used in conjunction with a delivery agent e.g. toothpaste to release Ca and P from the silica particles and methods of treatment using bioactive glass
EP97906489A EP0877716B1 (en) 1996-01-29 1997-01-29 Bioactive glass compositions for use in the treatment of tooth structures
AU21171/97A AU723659B2 (en) 1996-01-29 1997-01-29 Bioactive glass compositions and methods of treatment using bioactive glass
CA002244722A CA2244722C (en) 1996-01-29 1997-01-29 Bioactive glass compositions and methods of treatment using bioactive glass
NO983490A NO983490L (en) 1996-01-29 1998-07-29 Bioactive glass compositions and treatment methods using bioactive glass
BG102722A BG102722A (en) 1996-01-29 1998-08-25 Biologically active vitreous compositions and method for their treatment making use of biologically active glass
HK99104392A HK1019222A1 (en) 1996-01-29 1999-10-07 Bioactive glass compositions and methods of treatment using bioactive glass

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1079596P 1996-01-29 1996-01-29
US60/010,795 1996-01-29
US59793696A 1996-02-07 1996-02-07
US08/597,936 1996-02-07
USNOTFURNISHED 2006-03-02

Publications (2)

Publication Number Publication Date
WO1997027148A1 true WO1997027148A1 (en) 1997-07-31
WO1997027148A9 WO1997027148A9 (en) 1997-10-16

Family

ID=26681603

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/001785 WO1997027148A1 (en) 1996-01-29 1997-01-29 Bioactive glass compositions and methods of treatment using bioactive glass

Country Status (4)

Country Link
JP (2) JP4180657B2 (en)
HU (1) HUP9901760A3 (en)
PT (1) PT877716E (en)
WO (1) WO1997027148A1 (en)

Cited By (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999013852A1 (en) * 1997-09-18 1999-03-25 University Of Maryland, Baltimore Methods and compositions for whitening teeth
US5891233A (en) * 1994-10-06 1999-04-06 Bioxid Oy Use of bioactive silicious glass and new compositions containing bioactive silicious glass
WO2000015167A1 (en) 1998-09-10 2000-03-23 Usbiomaterials Corporation Anti-inflammatory and antimicrobial uses for bioactive glass compositions
US6086374A (en) * 1996-01-29 2000-07-11 Usbiomaterials Corp. Methods of treatment using bioactive glass
WO2000059460A1 (en) * 1999-04-07 2000-10-12 W.R. Grace & Co.-Conn. Additives for desensitizing and remineralizing dentifrice compositions
EP1049457A1 (en) * 1998-01-23 2000-11-08 Usbiomaterials Corporation Bioactive glass treatment of inflammation in skin conditions
US6190643B1 (en) 1999-03-02 2001-02-20 Patricia Stoor Method for reducing the viability of detrimental oral microorganisms in an individual, and for prevention and/or treatment of diseases caused by such microorganisms; and whitening and/or cleaning of an individual's teeth
EP1143919A1 (en) * 1999-01-20 2001-10-17 Usbiomaterials Corporation Composition and method for treating nails and adjacent tissues
US6338751B1 (en) 1996-02-07 2002-01-15 Usbiomaterials Corp Compositions containing bioactive glass and their use in treating tooth hypersensitivity
WO2002072038A1 (en) * 2001-03-09 2002-09-19 Schott Glas Use of bioactive glass in dental filling material
EP1272144A2 (en) * 2000-03-27 2003-01-08 Schott Glas New cosmetic, personal care, cleaning agent, and nutritional supplement compositions comprising bioactive glass and methods of making and using the same
DE10141230A1 (en) * 2001-08-22 2003-03-13 Schott Glas Color additive including a glass with an antimicrobial effect
WO2003050053A2 (en) * 2001-12-12 2003-06-19 Schott Glas Use of an antimicrobial glass ceramic for dental care and oral hygiene
WO2003074009A1 (en) * 2002-03-01 2003-09-12 Naerhi Timo Glass ionomers for enhancing mineralization of hard tissue
DE10214273A1 (en) * 2002-03-28 2003-10-23 Schott Glas Use of glass and/or glass ceramic powder and/or fiber for time- and quantity-controlled ion release is useful cosmetic or medicinal formulation as skin care cream and for healing or covering wound and treating chronic wound
WO2006072394A1 (en) * 2005-01-08 2006-07-13 Schott Ag Glass powder, especially biologically active glass powder, and method for producing glass powder, especially biologically active glass powder
US7166549B2 (en) 2001-08-22 2007-01-23 Schott Ag Antimicrobial, anti-inflammatory, wound-healing and disinfecting glass and use thereof
US7192602B2 (en) 2001-08-22 2007-03-20 Schott Ag Water-insoluble, antimicrobial silicate glass and use thereof
US7329126B2 (en) 2001-03-30 2008-02-12 King's College London Strand Use of bioactive glass
US7582310B2 (en) * 2002-09-02 2009-09-01 Seoul National University Industry Foundation Biodegradable and bioactive glass-ceramics, and method for fabricating the same
US7597900B2 (en) 2001-03-27 2009-10-06 Schott Ag Tissue abrasives
US7628997B1 (en) 1999-07-09 2009-12-08 Schott Ag Preservatives for perishable preparations, in particular for cosmetic and pharmaceutical preparations
US7709027B2 (en) 2001-08-22 2010-05-04 Schott Ag Antimicrobial, anti-inflammatory, wound-healing glass powder and use thereof
WO2011000866A3 (en) * 2009-06-30 2011-02-24 Repregen Limited Multicomponent glasses for use in personal care products
EP2306961A1 (en) * 2008-06-27 2011-04-13 Novamin Technology, Inc. Composition and method for enhancing flouride uptake using bioactive glass
WO2013034421A2 (en) 2011-09-08 2013-03-14 Unilever N.V. Tooth remineralizing dentifrice
WO2013149830A1 (en) 2012-04-05 2013-10-10 Unilever N.V. Non-aqueous oral care composition
WO2014056824A2 (en) 2012-10-12 2014-04-17 Unilever N.V. Oral care composition
CN104248775A (en) * 2014-09-22 2014-12-31 片仔癀（上海）生物科技研发有限公司 Hydroxyapatite-chitosan compound gel and preparation process and application thereof
EP2413882B1 (en) 2009-04-01 2016-11-16 Colgate-Palmolive Company Dual action dentifrice compositions to prevent hypersensitivity and promote remineralization
WO2017220835A1 (en) 2016-06-20 2017-12-28 Helicon Medical, S.L. Composition of materials for tooth remineralisation
WO2019034325A1 (en) 2017-08-18 2019-02-21 Unilever N.V. Oral care composition
WO2019034348A1 (en) 2017-08-18 2019-02-21 Unilever N.V. Oral care composition
WO2019108556A1 (en) * 2017-11-28 2019-06-06 Corning Incorporated Bioactive glass compositions and dentin hypersensitivity remediation
WO2019115601A1 (en) 2017-12-15 2019-06-20 Glaxosmithkline Consumer Healthcare (Uk) Ip Limited Novel composition
US10647962B2 (en) 2016-05-27 2020-05-12 Corning Incorporated Bioactive aluminoborate glasses
CN111494218A (en) * 2019-01-30 2020-08-07 广东东阳光药业有限公司 Bioactive glass
US10751367B2 (en) 2016-05-27 2020-08-25 Corning Incorporated Bioactive glass microspheres
US10857259B2 (en) 2017-11-28 2020-12-08 Corning Incorporated Chemically strengthened bioactive glass-ceramics
US10865133B2 (en) 2016-07-15 2020-12-15 Gc Corporation Dental glass and dental composition
CN113754556A (en) * 2021-09-29 2021-12-07 中国科学院过程工程研究所 Glass based on amino acid, preparation method and application thereof
US11198638B2 (en) 2017-11-28 2021-12-14 Corning Incorporated Bioactive borate glass and methods thereof
CN113975185A (en) * 2021-09-27 2022-01-28 深圳芳新悦享品牌管理有限公司 Toothpaste containing bioactive glass particles and preparation method thereof
US11266576B2 (en) 2019-08-01 2022-03-08 Vivekananda Ramana Dental enamel compositions with anti-inflammatory agents
US11351019B2 (en) 2019-08-01 2022-06-07 Vivekananda Ramana Dental enamel compositions with anti-inflammatory agents for animals
US11384009B2 (en) 2017-11-28 2022-07-12 Corning Incorporated High liquidus viscosity bioactive glass
US11814649B2 (en) 2016-05-27 2023-11-14 Corning Incorporated Lithium disilicate glass-ceramic compositions and methods thereof
US11950982B2 (en) 2022-04-19 2024-04-09 Vivekananda Ramana Dental enamel compositions with anti-inflammatory agents for animals

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0300644B8 (en) * 2003-02-20 2022-04-26 Fundacao Univ Federal De Sao Carlos Process of preparing particulate, bioactive and resorbable biosilicates, compositions for preparing said biosilicates and bioactive and resorbable particulate biosilicates.
EP2832342A3 (en) * 2004-11-16 2015-02-11 3M Innovative Properties Company of 3M Center Dental compositions with calcium phosphorus releasing glass
US20100086497A1 (en) * 2008-10-08 2010-04-08 Biofilm Limited Tooth remineralisation
RU2497496C2 (en) * 2008-11-25 2013-11-10 Дзе Проктер Энд Гэмбл Компани Antibacterial oral care compositions containing amorphous quartz
JP7028755B2 (en) * 2018-11-27 2022-03-02 ショット日本株式会社 Glass substrates with biocompatible through silicon vias and small biocompatible electronic devices

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057621A (en) * 1976-05-24 1977-11-08 Pashley David H Desensitizing oxalate dental composition and method of treatment
US4239113A (en) * 1977-06-02 1980-12-16 Kulzer & Co. Gmbh Composition for the preparation of bone cement
US4605415A (en) * 1982-12-02 1986-08-12 Region Wallonne, Representee Par L'executif Regional Wallon Bioreactive materials
US4775592A (en) * 1985-09-20 1988-10-04 G-C Dental Industrial Corp. Fluoroaluminosilicate glass powder for dental glass ionomer cement
US4783429A (en) * 1985-09-26 1988-11-08 Nippon Electric Glass Company, Limited No alkali containing biocompatible glass ceramic with apatite, wollastonite and diopside crystals mixed
US4851046A (en) * 1985-06-19 1989-07-25 University Of Florida Periodontal osseous defect repair
US5120340A (en) * 1989-09-06 1992-06-09 S.A. Fbfc International Bioreactive material for a prosthesis or composite implants
US5204106A (en) * 1989-04-20 1993-04-20 Fbfc International S.A. Process for restoring an osseous defect or deficiency by filling with osseous tissue
US5429996A (en) * 1992-10-09 1995-07-04 Nikon Corporation Bone grafting material

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4023744A1 (en) * 1990-07-26 1992-02-06 Thera Ges Fuer Patente USE OF GLASIONOMIC ELEMENT FOR CONTROLLED TISSUE REGENERATIONS
JP3277502B2 (en) * 1992-11-19 2002-04-22 株式会社トクヤマ Method for producing inorganic filler and dental restoration material

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057621A (en) * 1976-05-24 1977-11-08 Pashley David H Desensitizing oxalate dental composition and method of treatment
US4239113A (en) * 1977-06-02 1980-12-16 Kulzer & Co. Gmbh Composition for the preparation of bone cement
US4605415A (en) * 1982-12-02 1986-08-12 Region Wallonne, Representee Par L'executif Regional Wallon Bioreactive materials
US4851046A (en) * 1985-06-19 1989-07-25 University Of Florida Periodontal osseous defect repair
US4775592A (en) * 1985-09-20 1988-10-04 G-C Dental Industrial Corp. Fluoroaluminosilicate glass powder for dental glass ionomer cement
US4783429A (en) * 1985-09-26 1988-11-08 Nippon Electric Glass Company, Limited No alkali containing biocompatible glass ceramic with apatite, wollastonite and diopside crystals mixed
US5204106A (en) * 1989-04-20 1993-04-20 Fbfc International S.A. Process for restoring an osseous defect or deficiency by filling with osseous tissue
US5120340A (en) * 1989-09-06 1992-06-09 S.A. Fbfc International Bioreactive material for a prosthesis or composite implants
US5429996A (en) * 1992-10-09 1995-07-04 Nikon Corporation Bone grafting material

Cited By (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891233A (en) * 1994-10-06 1999-04-06 Bioxid Oy Use of bioactive silicious glass and new compositions containing bioactive silicious glass
US6086374A (en) * 1996-01-29 2000-07-11 Usbiomaterials Corp. Methods of treatment using bioactive glass
US6244871B1 (en) 1996-01-29 2001-06-12 Univ. Of Maryland Baltimore Bioactive glass compositions and methods of treatment using bioactive glass
US6338751B1 (en) 1996-02-07 2002-01-15 Usbiomaterials Corp Compositions containing bioactive glass and their use in treating tooth hypersensitivity
AU741771B2 (en) * 1997-09-18 2001-12-06 Novamin Technology, Inc. Methods and compositions for whitening teeth
BG65005B1 (en) * 1997-09-18 2006-12-29 Usbiomaterials Corporation Methods and compositions for teeth whitening
EP1011621A4 (en) * 1997-09-18 2000-12-27 Univ Maryland Methods and compositions for whitening teeth
EP1011621A1 (en) * 1997-09-18 2000-06-28 University of Maryland, Baltimore Methods and compositions for whitening teeth
WO1999013852A1 (en) * 1997-09-18 1999-03-25 University Of Maryland, Baltimore Methods and compositions for whitening teeth
US6365132B1 (en) * 1997-09-18 2002-04-02 Univ. Of Md., Baltimore Methods and compositions for whitening teeth
EP1049457A1 (en) * 1998-01-23 2000-11-08 Usbiomaterials Corporation Bioactive glass treatment of inflammation in skin conditions
EP1049457A4 (en) * 1998-01-23 2006-05-24 Usbiomaterials Corp Bioactive glass treatment of inflammation in skin conditions
EP1123072A4 (en) * 1998-09-10 2004-09-29 Usbiomaterials Corp Anti-inflammatory and antimicrobial uses for bioactive glass compositions
WO2000015167A1 (en) 1998-09-10 2000-03-23 Usbiomaterials Corporation Anti-inflammatory and antimicrobial uses for bioactive glass compositions
EP1123072A1 (en) * 1998-09-10 2001-08-16 Usbiomaterials Corporation Anti-inflammatory and antimicrobial uses for bioactive glass compositions
US6517863B1 (en) 1999-01-20 2003-02-11 Usbiomaterials Corporation Compositions and methods for treating nails and adjacent tissues
EP1143919A1 (en) * 1999-01-20 2001-10-17 Usbiomaterials Corporation Composition and method for treating nails and adjacent tissues
EP1143919A4 (en) * 1999-01-20 2002-07-24 Usbiomaterials Corp Composition and method for treating nails and adjacent tissues
US6342207B1 (en) 1999-03-02 2002-01-29 Patricia Stoor Method for reducing the viability of detrimental oral microorganisms in an individual, and for prevention and/or treatment of diseases caused by such microorganisms; and whitening and/or cleaning of an individual's teeth
US6190643B1 (en) 1999-03-02 2001-02-20 Patricia Stoor Method for reducing the viability of detrimental oral microorganisms in an individual, and for prevention and/or treatment of diseases caused by such microorganisms; and whitening and/or cleaning of an individual's teeth
WO2000059460A1 (en) * 1999-04-07 2000-10-12 W.R. Grace & Co.-Conn. Additives for desensitizing and remineralizing dentifrice compositions
EP1194113B1 (en) * 1999-07-09 2011-03-09 Schott AG Use of bioactive glass as a preservative for cosmetic and pharmaceutical preparations
US7628997B1 (en) 1999-07-09 2009-12-08 Schott Ag Preservatives for perishable preparations, in particular for cosmetic and pharmaceutical preparations
US8551508B2 (en) 1999-12-07 2013-10-08 Schott Ag Cosmetic, personal care, cleaning agent, and nutritional supplement compositions and methods of making and using same
US7250174B2 (en) 1999-12-07 2007-07-31 Schott Ag Cosmetic, personal care, cleaning agent, and nutritional supplement compositions and methods of making and using same
EP1272144A2 (en) * 2000-03-27 2003-01-08 Schott Glas New cosmetic, personal care, cleaning agent, and nutritional supplement compositions comprising bioactive glass and methods of making and using the same
EP1272144A4 (en) * 2000-03-27 2006-04-26 Schott Ag New cosmetic, personal care, cleaning agent, and nutritional supplement compositions comprising bioactive glass and methods of making and using the same
DE10111449A1 (en) * 2001-03-09 2002-09-26 Schott Glas Use of bioactive glass in tooth filling material
WO2002072038A1 (en) * 2001-03-09 2002-09-19 Schott Glas Use of bioactive glass in dental filling material
JP2004521135A (en) * 2001-03-09 2004-07-15 カール−ツァイス−スティフツング Use of bioactive glass for dental fillings
US7090720B2 (en) 2001-03-09 2006-08-15 Schott Ag Use of bioactive glass in dental filling material
US7597900B2 (en) 2001-03-27 2009-10-06 Schott Ag Tissue abrasives
US7329126B2 (en) 2001-03-30 2008-02-12 King's College London Strand Use of bioactive glass
US7709027B2 (en) 2001-08-22 2010-05-04 Schott Ag Antimicrobial, anti-inflammatory, wound-healing glass powder and use thereof
US7166549B2 (en) 2001-08-22 2007-01-23 Schott Ag Antimicrobial, anti-inflammatory, wound-healing and disinfecting glass and use thereof
US7192602B2 (en) 2001-08-22 2007-03-20 Schott Ag Water-insoluble, antimicrobial silicate glass and use thereof
DE10141230A1 (en) * 2001-08-22 2003-03-13 Schott Glas Color additive including a glass with an antimicrobial effect
WO2003050053A2 (en) * 2001-12-12 2003-06-19 Schott Glas Use of an antimicrobial glass ceramic for dental care and oral hygiene
WO2003050053A3 (en) * 2001-12-12 2003-09-04 Schott Glas Use of an antimicrobial glass ceramic for dental care and oral hygiene
WO2003074009A1 (en) * 2002-03-01 2003-09-12 Naerhi Timo Glass ionomers for enhancing mineralization of hard tissue
DE10214273A1 (en) * 2002-03-28 2003-10-23 Schott Glas Use of glass and/or glass ceramic powder and/or fiber for time- and quantity-controlled ion release is useful cosmetic or medicinal formulation as skin care cream and for healing or covering wound and treating chronic wound
US7582310B2 (en) * 2002-09-02 2009-09-01 Seoul National University Industry Foundation Biodegradable and bioactive glass-ceramics, and method for fabricating the same
WO2006072394A1 (en) * 2005-01-08 2006-07-13 Schott Ag Glass powder, especially biologically active glass powder, and method for producing glass powder, especially biologically active glass powder
EP2306961A1 (en) * 2008-06-27 2011-04-13 Novamin Technology, Inc. Composition and method for enhancing flouride uptake using bioactive glass
EP2306961A4 (en) * 2008-06-27 2014-07-02 Novamin Technology Inc Composition and method for enhancing flouride uptake using bioactive glass
EP2413882B1 (en) 2009-04-01 2016-11-16 Colgate-Palmolive Company Dual action dentifrice compositions to prevent hypersensitivity and promote remineralization
US9937365B2 (en) 2009-04-01 2018-04-10 Colgate-Palmolive Company Dual action dentifrice compositions to prevent hypersensitivity and promote remineralization
WO2011000866A3 (en) * 2009-06-30 2011-02-24 Repregen Limited Multicomponent glasses for use in personal care products
WO2013034421A2 (en) 2011-09-08 2013-03-14 Unilever N.V. Tooth remineralizing dentifrice
WO2013149830A1 (en) 2012-04-05 2013-10-10 Unilever N.V. Non-aqueous oral care composition
WO2014056824A2 (en) 2012-10-12 2014-04-17 Unilever N.V. Oral care composition
CN104248775A (en) * 2014-09-22 2014-12-31 片仔癀（上海）生物科技研发有限公司 Hydroxyapatite-chitosan compound gel and preparation process and application thereof
US10647962B2 (en) 2016-05-27 2020-05-12 Corning Incorporated Bioactive aluminoborate glasses
US11814649B2 (en) 2016-05-27 2023-11-14 Corning Incorporated Lithium disilicate glass-ceramic compositions and methods thereof
US10751367B2 (en) 2016-05-27 2020-08-25 Corning Incorporated Bioactive glass microspheres
WO2017220835A1 (en) 2016-06-20 2017-12-28 Helicon Medical, S.L. Composition of materials for tooth remineralisation
US10865133B2 (en) 2016-07-15 2020-12-15 Gc Corporation Dental glass and dental composition
WO2019034348A1 (en) 2017-08-18 2019-02-21 Unilever N.V. Oral care composition
WO2019034325A1 (en) 2017-08-18 2019-02-21 Unilever N.V. Oral care composition
US11446410B2 (en) 2017-11-28 2022-09-20 Corning Incorporated Chemically strengthened bioactive glass-ceramics
US11274059B2 (en) 2017-11-28 2022-03-15 Corning Incorporated Bioactive glass compositions and dentin hypersensitivity remediation
WO2019108556A1 (en) * 2017-11-28 2019-06-06 Corning Incorporated Bioactive glass compositions and dentin hypersensitivity remediation
US11198638B2 (en) 2017-11-28 2021-12-14 Corning Incorporated Bioactive borate glass and methods thereof
US11384009B2 (en) 2017-11-28 2022-07-12 Corning Incorporated High liquidus viscosity bioactive glass
US10857259B2 (en) 2017-11-28 2020-12-08 Corning Incorporated Chemically strengthened bioactive glass-ceramics
CN111405913A (en) * 2017-11-28 2020-07-10 康宁股份有限公司 Bioactive glass compositions and dentinal hypersensitivity repair
WO2019115601A1 (en) 2017-12-15 2019-06-20 Glaxosmithkline Consumer Healthcare (Uk) Ip Limited Novel composition
CN111494218A (en) * 2019-01-30 2020-08-07 广东东阳光药业有限公司 Bioactive glass
US11654088B2 (en) 2019-08-01 2023-05-23 Vivekananda Ramana Dental enamel compositions with anti-inflammatory agents
US11351019B2 (en) 2019-08-01 2022-06-07 Vivekananda Ramana Dental enamel compositions with anti-inflammatory agents for animals
US11266576B2 (en) 2019-08-01 2022-03-08 Vivekananda Ramana Dental enamel compositions with anti-inflammatory agents
CN113975185B (en) * 2021-09-27 2023-06-23 深圳小爱大爱科技有限责任公司 Toothpaste containing bioactive glass particles and preparation method thereof
CN113975185A (en) * 2021-09-27 2022-01-28 深圳芳新悦享品牌管理有限公司 Toothpaste containing bioactive glass particles and preparation method thereof
CN113754556A (en) * 2021-09-29 2021-12-07 中国科学院过程工程研究所 Glass based on amino acid, preparation method and application thereof
US11950982B2 (en) 2022-04-19 2024-04-09 Vivekananda Ramana Dental enamel compositions with anti-inflammatory agents for animals
US11951192B2 (en) 2023-04-14 2024-04-09 Vivekananda Ramana Dental enamel compositions with anti-inflammatory agents

Also Published As

Publication number Publication date
HUP9901760A2 (en) 1999-10-28
JP5020833B2 (en) 2012-09-05
JP2008120681A (en) 2008-05-29
JP2001525779A (en) 2001-12-11
JP4180657B2 (en) 2008-11-12
HUP9901760A3 (en) 1999-11-29
PT877716E (en) 2005-02-28

Similar Documents

Publication Publication Date Title
US6086374A (en) Methods of treatment using bioactive glass
WO1997027148A1 (en) Bioactive glass compositions and methods of treatment using bioactive glass
WO1997027148A9 (en) Bioactive glass compositions and methods of treatment using bioactive glass
US5735942A (en) Compositions containing bioactive glass and their use in treating tooth hypersensitivity
RU2152778C1 (en) Preparation for alleviating pulp irritation and/or reinforcing tooth structure
WO2013040952A1 (en) Composition and method for prevention or treatment of dentin-related symptoms or diseases
US20120202174A1 (en) Process for laser treatment of dental cavities, biomaterial for realisation and use thereof
Hsu et al. The combined occluding effects of fluoride-containing dentin desensitizer and Nd-Yag laser irradiation on human dentinal tubules: an in vitro study
Bakry et al. Invitro evaluation of new treatment for dentin hypersensitivity using BioMin F and BioMin C
CN110859767B (en) Bioactive glass composition, and preparation method and application thereof
MXPA98006105A (en) Bioactive glass compositions and treatment methods that use bioact glass
Sabbah Microleakage of cavity Class V restored by glass ionomer restorations in primary molars conditioned by Er, Cr: YSGG laser versus conventional method (an in vitro study)
Omran et al. Assessment of Remineralizing Effect of Bioactive Glass Based Toothpastes: an In-Vitro Comparative Study
Haridy et al. Micro Hardness Of Bleached Human Enamel Following Application Of Conventional Versus Nano Active Bioglass: An Invitro Study
Sadabadi et al. Evaluation of the Effect of NovaMin and Er, Cr: YSGG Laser on Remineralization of Erosive Lesions of Primary Enamel Teeth: An In Vitro Study
Sherif et al. REMINERALIZATION EFFICIENCY OF NANOHYDROXYAPATITE, NANO-BIOACTIVE GLASS, AND SODIUM FLUORIDE ON INITIAL ENAMEL CARIES OF PRIMARY TEETH
Khan et al. Protecting Eroded Dentine Against Multiple Acid Challenge with Bioglass
WO2021047971A1 (en) Method for remineralizing and/or reducing sensitivity of teeth
Zeiger The effects of bioactive glass on bonding to dentin
Toledano Pérez et al. Functional and molecular structural analysis of dentine interfaces promoted by a Zn-doped self-etching adhesive and an in vitro load cycling model
Halkai Rahul et al. Evaluation of Effectiveness of Mineral Trioxide Aggregate for Root Furcation Repair Using Diode Laser as Adjunct-An In Vitro Study

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 97193085.6

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG

COP Corrected version of pamphlet

Free format text: PAGES 1/11-11/11, DRAWINGS, REPLACED BY NEW PAGES 1/12-12/12; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2244722

Country of ref document: CA

Ref document number: 2244722

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PV1998-2395

Country of ref document: CZ

Ref document number: 1019980705836

Country of ref document: KR

Ref document number: PA/a/1998/006105

Country of ref document: MX

Ref document number: 102998

Country of ref document: SK

Ref document number: 1998/01523

Country of ref document: TR

Ref document number: 98-01238

Country of ref document: RO

WWE Wipo information: entry into national phase

Ref document number: 331514

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 1997906489

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 1997US 9701785

Country of ref document: KE

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1997US9701785

Country of ref document: KE

WWE Wipo information: entry into national phase

Ref document number: 1199800744

Country of ref document: VN

WWP Wipo information: published in national office

Ref document number: 1997906489

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: PV1998-2395

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 1019980705836

Country of ref document: KR

WWR Wipo information: refused in national office

Ref document number: PV1998-2395

Country of ref document: CZ

WWG Wipo information: grant in national office

Ref document number: 1997906489

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1019980705836

Country of ref document: KR